Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news



Pfizer slammed for UK infant formula advertising code breach

By Mark Astley , 28-Nov-2012

The complaint related to an email advertising SMA First Infant Milk.

The complaint related to an email advertising SMA First Infant Milk.

SMA Nutrition manufacturer Pfizer has been scolded by the UK Advertising Standards Authority (ASA) for breaching an advertising code relating to the promotion of infant formula products.

The ASA upheld one of two complaints made against a May 2012 email sent by Pfizer to mothers of young children, offering advice on breastfeeding. The emails also made suggestions about combination feeding under the title, “Considering combination feeding?”

Another section of the email - titled “Thinking of Bottle Feeding?” - was accompanied by a picture of SMA First Infant Milk and a statement boasting of the products “protein profile and a new fat blend.”

According to Baby Milk Action – which was behind the original complaint - the email played on fears about milk intake and possible problems with breastfeeding, before promoting SMA infant formula. approached Pfizer UK for comment on the ASA decision, but no one from the company was available prior to publication.

Breached ASA code

Baby Milk Action, which works to strengthen controls on baby food marketing, challenged whether the email breached the UK Advertising Code on two points – that it promoted infant formula and that it was sent without explicit consent.

The ASA upheld that the email breached Clause 15.10, which prohibits marketing communications for infant formula “except for those in a scientific publication or, for the purposes of trade before the retail stage, a publication of which the intended readers are not the general public.”

The second complaint was not upheld by the ASA.

“Because we considered that the email was an advertisement for the purposes of Code rule 15.10, we concluded that it was within the remit of the ASA and breached the Code by promoting infant formula,” said the ASA decision.

“The ad must not appear again in its current form. We told SMA not to produce marketing communications for infant formula except in a scientific publication or, for the purposes of trade before the retail stage, a publication of which the intended readers were not the general public,” the ASA decision concluded.

‘Despicable’ email campaign

Baby Milk Action has welcomed the ASA decision, labelling Pfizer’s email campaign as “despicable.”

“Pfizer/Wyeth can add this latest ruling against its marketing strategies to the others and its 2003 criminal conviction for a ‘cynical and deliberate breach of the regulations’ at that time,” said Baby Milk Action campaigns and networking co-ordinator, Mike Brady.

“The fact it thinks it can continue to get away with showing utter contempt for the regulations speaks volumes about how it puts its own profits before the well-being of babies and their families.”

“This email campaign was particularly despicable as it targeted mothers when their babies are four weeks of age and plays on fears and problems they may be experiencing with breastfeeding to push Pfizer/Wyeth’s SMA brand of formula,” Brady added.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars

Promotional Features